{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T23:38:01Z","timestamp":1720481881611},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.2169\/internalmedicine.0264-22","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T22:12:18Z","timestamp":1658441538000},"page":"689-695","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy"],"prefix":"10.2169","volume":"62","author":[{"given":"Ryutaro","family":"Taenaka","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, JCHO Kyushu Hospital, Japan"},{"name":"Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JCHO Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JCHO Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JCHO Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JCHO Kyushu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ley TJ, Miller C, Ding L, et al.; Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult <i>de novo<\/i> acute myeloid leukemia. N Engl J Med 368: 2059-2074, 2013.","DOI":"10.1056\/NEJMoa1301689"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dombret H, Seymour JF, Butrym A, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with &gt;30% blasts. Blood 126: 291-299, 2015.","DOI":"10.1182\/blood-2015-01-621664"},{"key":"3","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"3. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 96: 3671-3674, 2000.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wheatley K, Brookes CL, Howman AJ, et al. Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. Br J Haematol 145: 598-605, 2009.","DOI":"10.1111\/j.1365-2141.2009.07663.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kanda Y. Investigation of the freely available easy-to-use software &quot;EZR&quot; for medical statistics. Bone Marrow Transplant 48: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 14: 42, 2016.","DOI":"10.1186\/s12959-016-0117-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kantarjian H, Giles F, List A, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 109: 1705-1714, 2007.","DOI":"10.1002\/cncr.22602"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Li W, Morrone K, Kambhampati S, Will B, Steidl U, Verma A. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies. Leukemia 30: 536-544, 2016.","DOI":"10.1038\/leu.2015.297"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383: 617-629, 2020.","DOI":"10.1056\/NEJMoa2012971"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Itzykson R, Th\u00e9pot S, Quesnel B, et al. Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. Blood 117: 403-411, 2011.","DOI":"10.1182\/blood-2010-06-289280"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bujak K, Wasilewski J, Osadnik T, et al. The prognostic role of red blood cell distribution width in coronary artery disease: a review of the pathophysiology. Dis Markers 2015: 824624, 2015.","DOI":"10.1155\/2015\/824624"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ai L, Mu S, Hu Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis. Cancer Cell Int 18: 61, 2018.","DOI":"10.1186\/s12935-018-0558-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133: 628-632, 2009.","DOI":"10.5858\/133.4.628"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Peri\u0161a V, Zibar L, Sin\u010di\u0107-Petri\u010devi\u0107 J, Knezovi\u0107 A, Peri\u0161a I, Barbi\u0107 J. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croat Med J 56: 334-343, 2015.","DOI":"10.3325\/cmj.2015.56.334"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_0264-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:37Z","timestamp":1715315497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_0264-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0264-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"0264-22"}}